Kevin P. Smith
Kevin P. Smith is the General Counsel and EVP for Business Development at Sirtex Medical. In this role, Kevin focuses on growing the product portfolio of the company in the interventional radiology and oncology markets, as well as managing the risks to the business.
Before joining Sirtex in 2018, Kevin served as VP and Associate General Counsel at Flexion Therapeutics, managing intellectual property and corporate governance. Prior to that, he was General Counsel for the Danaher Life Sciences Platform, leading the legal, compliance, and intellectual property functions for the operating companies within the platform. Kevin has also held senior legal leadership positions within Novartis Pharmaceuticals in Switzerland and Massachusetts, including as General Counsel for the Novartis Molecular Diagnostics Unit, focused on developing tools to further personalized medicine solutions. Before moving in-house, Kevin worked for multinational law firms in New York, Silicon Valley, and London.
A member of the California, Massachusetts, and New York State bars, Kevin is also a registered patent attorney with the U.S. Patent and Trademark Office. He also serves as a Director for the non-profit, National Immigration Litigation Alliance, as well as being a Director for BlackSwan Vascular, Inc. and Nanospectra Biosciences, Inc.